XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Cash flows from operating activities    
Net income (loss) $ (2,649) $ (65,385)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,576 4,684
Non-cash operating lease cost 1,963 1,749
Stock-based compensation 35,870 2,100
Amortization of deferred contract acquisition costs 829 538
Change in fair value of redeemable convertible preferred stock warrant liability (9,237) 10,981
Change in fair value of common stock warrant liabilities (33,340) 10,981
Change in fair value of contingent earnout liability (84,420)  
Transaction costs expensed 7,031  
Other 1,236 683
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable, net (7,657) 16,188
Inventories 5,620 (7,427)
Prepaid expenses and other assets (9,325) (3,335)
Operating lease liabilities (953) (2,031)
Accounts payable 9,293 (9,324)
Accrued and other liabilities 3,027 (4,054)
Deferred revenue 15,938 4,564
Net cash used in operating activities (61,198) (50,069)
Cash flows from investing activities    
Purchases of property and equipment (7,788) (5,962)
Maturities of investments   47,014
Net cash (used in) provided by investing activities (7,788) 41,052
Cash flows from financing activities    
Proceeds from the exercise of public warrants 117,598 31,390
Proceeds from issuance of redeemable convertible preferred stock   92,433
Merger and PIPE financing 511,646  
Payment of transaction costs related to Merger (32,468)  
Payment of tax withholding obligations on settlement of earnout shares (20,894)  
Repayment of borrowings (36,051)  
Proceeds from exercises of vested and unvested stock options 1,759 1,542
Net cash provided by financing activities 541,590 125,365
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (6) 36
Net increase in cash, cash equivalents, and restricted cash 472,598 116,384
Cash, cash equivalents, and restricted cash at beginning of period 145,491 73,153
Cash, cash equivalents, and restricted cash at end of period 618,089 189,537
Supplementary cash flow information    
Cash paid for interest 344 1,402
Cash paid for taxes 115 105
Supplementary cash flow information on noncash investing and financing activities    
Accretion of beneficial conversion feature of redeemable convertible preferred stock   $ 58,625
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization 615,697  
Reclassification of Legacy ChargePoint redeemable convertible preferred stock warrant liability upon the reverse capitalization 66,606  
Contingent earnout liability recognized upon the closing of the reverse recapitalization 828,180  
Reclassification of remaining contingent earnout liability upon triggering event $ 242,640